BioStem Technologies, Inc. (BSEM)
OTCMKTS · Delayed Price · Currency is USD
4.720
+0.120 (2.61%)
At close: Apr 28, 2026

BioStem Technologies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
---8.48-7.19-1.45
Upgrade
Depreciation & Amortization
--0.230.220.28
Upgrade
Other Amortization
--0.17--
Upgrade
Loss (Gain) From Sale of Assets
-----0.03
Upgrade
Stock-Based Compensation
--6.675.381.19
Upgrade
Provision & Write-off of Bad Debts
---0.15-
Upgrade
Other Operating Activities
--0.642.04-0.62
Upgrade
Change in Accounts Receivable
---11.330.11-0.29
Upgrade
Change in Inventory
---0.26-0.140.21
Upgrade
Change in Accounts Payable
--0.82-0.08-0.02
Upgrade
Change in Other Net Operating Assets
--8.06-0.20.61
Upgrade
Operating Cash Flow
---3.50.3-0.11
Upgrade
Capital Expenditures
---0.11-0.24-0.04
Upgrade
Cash Acquisitions
---0.11-0.23-
Upgrade
Divestitures
----0.04
Upgrade
Investing Cash Flow
---0.21-0.47-0.01
Upgrade
Long-Term Debt Issued
--1.571.10.3
Upgrade
Total Debt Issued
--1.571.10.3
Upgrade
Long-Term Debt Repaid
---0.77-0.55-0.06
Upgrade
Total Debt Repaid
---0.77-0.55-0.06
Upgrade
Net Debt Issued (Repaid)
--0.80.550.23
Upgrade
Issuance of Common Stock
--2.380.050.13
Upgrade
Financing Cash Flow
--3.180.60.36
Upgrade
Net Cash Flow
---0.530.430.24
Upgrade
Free Cash Flow
---3.60.06-0.15
Upgrade
Free Cash Flow Margin
---21.60%0.87%-3.51%
Upgrade
Free Cash Flow Per Share
---0.260.01-0.01
Upgrade
Cash Interest Paid
--0.480.230.33
Upgrade
Levered Free Cash Flow
---0.610.77-
Upgrade
Unlevered Free Cash Flow
---0.341.07-
Upgrade
Change in Working Capital
---2.72-0.30.52
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.